+ All Categories
Home > Documents > Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass

Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass

Date post: 05-Jan-2016
Category:
Upload: prince
View: 26 times
Download: 1 times
Share this document with a friend
Description:
59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria. Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass TURBT&PROSTATE Bx was done. Bladder :High grade TCC+CIS prostate :GS 3+4. GI biopsy :NL. - PowerPoint PPT Presentation
Popular Tags:
26
Transcript
Page 1: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 2: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

59 years old manHx of stomach adenocarcinoma 20 years agoHx of chemoradiotherapycc:gross hematuria

Page 3: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass

TURBT&PROSTATE Bx was done

Page 4: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 5: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Bladder:High grade TCC+CIS

prostate:GS 3+4

Page 6: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

GI biopsy :NL

Page 7: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

RADICAL CYSTOPROSTATECTOMY WAS DONEUreteral frozen sections:negative

Page 8: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

EAU

In all T1 tumours at high risk of progression (i.e. high grade, multifocality, carcinoma in situ, and tumour size, as outlined in the EAU EAU: European Association of Urologyguidelines for Non-muscle-invasive bladder cancer [32]), immediate radical cystectomy is an option.

In all T1 patients failing intravesical therapy, cystectomy should be performed.

Page 9: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 10: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Urothelial CIS with prostatic duct involvementprostate:GS 3+3left ureter:CIS

Page 11: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 12: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

18 MONTHS AFTER RADICAL CYSTECTOMY URIN CYTOLOGY IS POITIVE

Page 13: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 14: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 15: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 16: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass
Page 17: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

CYTOLOGY:NEG

23.1.93

Page 18: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

In the case of CIS, an attempt is made to achieve a negative margin without compromising ureteral length because nephrectomy is not indicated for CIS of the uretCIS of the ureter is not independently associated with a worse outcome following cystectomy (Lee et al, 2006). Cancer recurrence at the anastomosis is rare even with a positive margin showing CIS, but a positive margin is a risk factor for developing a second primary tumor of the ureter or renal pelvis (Lee et al, 2006; Raj et al, 2006).

Page 19: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Surveillance ureteroscopy is the most sensitive means for following patients with a positive ureteral margin, and long-term follow-up is required. The median time to occurrence in one recent series was 53 months (Wagner et al, 2008).

Page 20: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

BJU Int. 2012 Mar;109(6):846-54. doi: 10.1111/j.1464-410X.2011.10455.x. Epub 2011 Aug 4.Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

Bladder cancer recurrence forebodes poor prognosis, with 6 months' median survival following recurrence. Advanced pathological stage, positive surgical margins, high lymph node density and early recurrence portends poorer outcome. Although patients with local recurrence have a slightly better prognosis, those with disease recurrence at local and distant sites perform very poorly; nearly 97% of all patients with recurrence eventually succumb to the disease. Chemotherapy administration following recurrence may improve survival, although further studies are needed to exclude selection bias.

Page 21: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

J Urol. 2010 Jun;183(6):2165-70. doi: 10.1016/j.juro.2010.02.021.Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.

Positive soft tissue surgical margin is a strong predictor of recurrence and eventual death from urothelial carcinoma of the bladder. Soft tissue surgical margin status should always be reported in the pathological reports after radical cystectomy. Due to uniformly poor outcomes patients with positive soft tissue surgical margins should be considered for studies on adjuvant local and/or systemic therapy.

Page 22: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Eur Urol. 2013 Apr;63(4):739-44. doi: 10.1016/j.eururo.2012.09.053. Epub 2012 Sep 28.Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.

CONCLUSIONS: We present the first explorative study on the prognostic impact of pnLVI. In contrast to other parameters that show the extent of LN metastasis, pnLVI is an independent prognosticator for CSS.

Page 23: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Prog Urol. 2012 Oct;22(12):705-10. doi: 10.1016/j.purol.2012.07.011. Epub 2012 Aug 29.[Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins].

Positive soft tissue surgical margin and/or lymph node metatstasis on cystectomy specimen is a strong predictor of GS and SS from urothelial carcinoma of the bladder. So it is for capsular rupture, ganglionic density greater or equal to 0.10 and nb of N in lymphadenectomy less than 14 for pN+ patients.

Page 24: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

J Urol. 2007 Dec;178(6):2308-12; discussion 2313. Epub 2007 Oct 22.Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Risk factors for positive soft tissue surgical margins are female gender, locally advanced cancer, presence of vascular invasion and mixed histology. Patients with positive soft tissue surgical margins have poor prognosis, and positive soft tissue surgical margins were found to be independently associated with disease specific death.

Page 25: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

World J Urol. 2011 Aug;29(4):451-6. doi: 10.1007/s00345-010-0581-z. Epub 2010 Jul 9.Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis.

FSA has a high accuracy for detecting malignant ureteral margins. Patients with positive final margins are at increased risk of UUT-R. With sequential resection, however, positive margins cannot reliably be converted to negative ones.

Page 26: Cytology:doubtful  malignancy PSA: 4.9     5.5 Cr: 1.1 USG: Bladder mass

Int Urol Nephrol. 2012 Dec;44(6):1705-10. doi: 10.1007/s11255-012-0224-y. Epub 2012 Jul 7.The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens.

The majority of incidental CaP in CP specimens are organ confined and do not influence oncological outcome. The prognosis of such patients is primarily determined by bladder cancer. Our findings support previous reports and autopsy studies elsewhere.


Recommended